OR WAIT null SECS
March 01, 2013
A roundtable discussion of the challenges and innovations in tablet splitting featuring Freeman Technology, Accu-Break Pharmaceuticals, and Medelpharm.
An alternative chapter has been added to the European Pharmacopoeia for dosage uniformity.
February 21, 2013
A GBI Research report says the opioid market will be driven by development of new products and post-marketing studies designed to reduce abuse risk.
December 02, 2012
GlaxoSmithKline recently developed a novel technology for the formulation of modified-release tablets. The authors describe the route from development to commercialization.
A look at the year's leaders in innovation strategy, including the top bio/pharmaceutical companies and award recipients from AAPS, PhRMA, and CPhI.
November 21, 2012
German Court Finds AstraZeneca's Seroquel XR Formulation Patent Invalid; FDA Advisory Committee to Recommend Approval of GSK's H5N1 Influenza Vaccine Candidate; and More.
November 01, 2012
The authors describe a process for generating high affinity, fully human antibodies in culture.
October 17, 2012
Consider these tools and strategies for optimizing the manufacturing process.
October 02, 2012
Recent research on elucidating the structure and sequence of proteins involves examining the effect of microgravity on protein crystallization and a computational model for protein elucidation.
Potency is a required measurement to determine the amount of active ingredient contained in a preclinical dose formulation. Assessing potency ensures that the test system receives the appropriate amount of active ingredient based on predetermined specifications.